What is the difference between continuous monitoring and a software bill of materials for medical devices?

Continuous monitoring tracks the device’s security posture over time, looking for abnormal activity, emerging vulnerabilities, and operational drift after deployment. A software bill of materials is an inventory of the software components in the device, including known vulnerability information. Monitoring tells you what is happening now, while the SBOM tells you what is inside the device.

How continuous monitoring and an SBOM solve different medical device problems

They answer different questions at different points in the device lifecycle. An SBOM is a static inventory of what software is present, which helps you understand composition, component provenance, and where known vulnerable packages may exist. continuous monitoring is operational, watching the deployed device for abnormal behavior, drift, exposure, and signs that the risk picture has changed after release.

That distinction matters because a device can ship with a clean bill of materials and still become risky later through misconfiguration, environmental change, or newly discovered vulnerabilities. It can also have a noisy or incomplete operational picture without changing what software is inside. For medical devices, you usually need both views to avoid blind spots.

What the SBOM tells you, and what it cannot tell you

An SBOM is best understood as a structured inventory of components, not a runtime defense. It tells clinicians, biomedical engineers, and security teams which libraries, packages, and embedded dependencies are present so they can compare those components against vulnerability disclosures and support patch prioritization. The value is traceability: if a vulnerable component is identified, you know whether the device includes it.

What it cannot tell you is whether the device is currently behaving safely. An SBOM does not show whether a service is talking to an unexpected destination, whether configuration drift has opened an exposure path, or whether a device has been tampered with after deployment. For that reason, SLSA and SBOM-style inventory thinking are complementary, but they do not replace runtime visibility.

In practice, SBOMs are strongest for procurement, assurance, and vulnerability response. They help answer, “What is inside this device?” and “Could a known issue affect us?” They are weaker for operational assurance because they are only as current as the last release artifact or update cycle.

What continuous monitoring adds after deployment

Continuous monitoring addresses the live device state. It looks for suspicious traffic, unexpected services, integrity changes, new exposures, and indicators that the device’s security posture has drifted since it was installed. In a hospital setting, that matters because devices are often long-lived, network-reachable, and embedded in environments where patching may be delayed for safety, compatibility, or regulatory reasons.

Monitoring is therefore the control that reveals change, while the SBOM is the control that reveals composition. If a device starts communicating in ways that do not fit its normal function, monitoring may surface the issue even when the software stack has not changed. If a vulnerable library is later disclosed, the SBOM helps you identify affected models quickly, even if the device has not yet shown malicious behavior.

For defenders, the most useful comparison is operational: the SBOM supports exposure identification, while monitoring supports detection and response. One is about known contents; the other is about observed behavior. A program that relies on only one will miss part of the risk picture.

Why the difference matters for medical device governance

Medical devices create a special governance problem because clinical availability, patient safety, and vendor support windows all constrain what can be changed and when. That is why CIS Benchmarks are useful for understanding hardening expectations, but they still need to be paired with device-specific visibility and inventory. A strong inventory without monitoring can leave a compromise undetected. Strong monitoring without inventory can tell you something is wrong, but not what component or release introduced the issue.

The practical governance issue is correlation. When a vulnerability bulletin lands, the SBOM helps you determine whether the device is exposed. When an alert fires, monitoring helps you determine whether the device is behaving like the known-good baseline. Together they support faster triage, better vendor escalation, and more defensible risk acceptance decisions.

For hospitals and device operators, the most common failure is treating SBOM collection as the whole security program. It is not. The more devices are connected, the more the operational question matters: what has changed, what is abnormal, and what can be trusted now?

Standards & Framework Alignment

This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.

CIS Controls v8 and NIST SP 800-53 Rev 5 set the governance and control requirements practitioners need to meet.

Framework	Control / Reference	Relevance
CIS Controls v8	CIS-7 — Continuous Vulnerability Management	SBOMs support identifying exposed components for vulnerability management.
	CIS-4 — Secure Configuration of Enterprise Assets and Software	Continuous monitoring detects configuration drift and exposure changes in deployed medical devices.
Recommendation — Use CIS-7 to inventory affected components and prioritize remediation when vulnerable software is present. Use CIS-4 to baseline device settings and detect drift from approved configurations.
NIST SP 800-53 Rev 5	RA-5 — Vulnerability Monitoring and Scanning	The question contrasts component inventory with ongoing vulnerability awareness after deployment.
	CM-8 — System Component Inventory	An SBOM is fundamentally a component inventory for the device software stack.
	SI-4 — System Monitoring	Continuous monitoring is about observing device behavior and security posture over time.
Recommendation — Apply RA-5 to track newly disclosed vulnerabilities against the device's software inventory. Use CM-8 to maintain an accurate component inventory tied to the exact device release. Use SI-4 to detect abnormal activity, integrity changes, and operational drift.

Practitioner Guidance

What to prioritize: Use the SBOM first to establish inventory and exposure scope, then use continuous monitoring to define what normal device behavior looks like and to detect drift from that baseline. If a device has no trustworthy inventory, you will spend too long identifying what is affected; if it has no monitoring, you may never know that an issue has become active.

What to verify: Confirm that the SBOM is tied to the exact device model, software release, and update state in service. Then verify that monitoring is tuned to device-specific behaviors, not generic endpoint assumptions, because many medical devices cannot tolerate aggressive agents or noisy telemetry.

Practitioner takeaway: Treat the SBOM as your source of composition truth and continuous monitoring as your source of operational truth, and do not let either one be mistaken for a complete security view.